[ANAB] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[ANAB] AnaptysBio, Inc.
Announcement Date
25-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 241.57%
YoY- 266.05%
Quarter Report
ANAB's Result
ANAB's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 9,005 6,808 1,011 60,000 3,000 0 3,000 20.09%
PBT -42,215 -26,389 -32,538 33,646 -20,285 -17,186 -6,861 35.34%
Tax 4,874 24 -1,450 -75 -22 -192 293 59.73%
NP -42,211 -26,413 -32,538 33,646 -20,263 -16,994 -6,861 35.34%
Tax Rate - - - 0.22% - - - -
Total Cost 51,216 33,221 33,549 26,354 23,263 16,994 9,861 31.58%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -468.75 -387.97 -3,218.40 56.08 -675.43 0.00 -228.70 12.69%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.59 -0.93 -1.18 1.23 -0.75 -0.64 -0.30 32.02%
EPS Diluted -1.59 -0.93 -1.18 1.23 -0.75 -0.63 -0.30 32.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.